{
  "id": 2018,
  "text": "Rising levels of SCC-Ag1 and SCC-Ag2 were seen in patients with recurrence or progressive disease.The rise in SCC-Ag2 was usually more prominent than in SCC-Ag1.However, SCC-Ag2 did not show improved tumour specificity as compared with SCC-Ag1 or total SCC-Ag.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Rising levels of SCC-Ag1 and SCC-Ag2 were seen in patients with recurrence or progressive disease.The rise in SCC-Ag2 was usually more prominent than in SCC-Ag1.However, SCC-Ag2 did not show improved tumour specificity as compared with SCC-Ag1 or total SCC-Ag.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "在宫颈癌复发或进展的过程中，SCC-Ag1和SCC-Ag2的水平都有上升的表现。然而，SCC-Ag2的上升通常比SCC-Ag1更为显著。尽管如此，SCC-Ag2在肿瘤特异性方面并没有显示出比SCC-Ag1或总SCC-Ag更高的改善。因此，在实际临床应用中，SCC-Ag2可能在监测疾病进展时显示出更明显的变化，但在特异性方面并没有明显优势。",
  "query": "SCC-Ag1和SCC-Ag2在区分宫颈癌复发或进展时有什么不同表现？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: SCC-Ag1和SCC-Ag2在区分宫颈癌复发或进展时有什么不同表现？\n\n<reference text>: Rising levels of SCC-Ag1 and SCC-Ag2 were seen in patients with recurrence or progressive disease.The rise in SCC-Ag2 was usually more prominent than in SCC-Ag1.However, SCC-Ag2 did not show improved tumour specificity as compared with SCC-Ag1 or total SCC-Ag.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "在宫颈癌复发或进展的过程中，SCC-Ag1和SCC-Ag2的水平都有上升的表现。然而，SCC-Ag2的上升通常比SCC-Ag1更为显著。尽管如此，SCC-Ag2在肿瘤特异性方面并没有显示出比SCC-Ag1或总SCC-Ag更高的改善。因此，在实际临床应用中，SCC-Ag2可能在监测疾病进展时显示出更明显的变化，但在特异性方面并没有明显优势。"
}